-
781
Immunotherapy targeting isoDGR‐protein damage extends lifespan in a mouse model of protein deamidation
Published 2023-11-01“…Mechanistically, isoDGR‐mAb mediated immune clearance of damaged isoDGR‐proteins via antibody‐dependent cellular phagocytosis (ADCP). These results indicate that immunotherapy targeting age‐linked protein damage may represent an effective intervention strategy in a range of human degenerative disorders.…”
Get full text
Article -
782
Age-associated defect in ADCC response to COVID-19 vaccine
Published 2025-07-01“…While neutralization titers remained comparable across age groups, Fc-mediated effector functions declined with age. Individuals >80 demonstrated reduced antibody-dependent cellular cytotoxicity (ADCC), via a surrogate ADCC-signaling assay, correlating with diminished IgG1 binding. …”
Get full text
Article -
783
Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study
Published 2024-12-01“…Daiana Stolz,1,2 Claudio Schuoler,3 Florian Charbonnier,4 Pierre-Olivier Bridevaux,4,5 Peter Jandus,6 Jörg D Leuppi,7 Nikolay Pavlov,8 Andreas Piecyk,9 Thomas Rothe10 1Pulmonology Clinic, University Hospital Basel, Basel, Switzerland; 2Clinic of Respiratory Medicine and Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3Medical Department, AstraZeneca AG, Baar, Switzerland; 4Pulmonology Division, University Hospital Geneva, Geneva, Switzerland; 5Service de Pneumologie, Centre Hospitalier du Valais Romand, Sion, Switzerland; 6Immunology and Allergology Division, University Hospital Geneva, Geneva, Switzerland; 7University Centre of Internal Medicine, Cantonal Hospital Baselland, Liestal, Switzerland; 8Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 9Pulmonary Center Hirslanden, Zurich, Switzerland; 10Pulmonology Clinic, Cantonal Hospital Graubünden, Chur, SwitzerlandCorrespondence: Claudio Schuoler, AstraZeneca AG, Medical Department, Baar, Switzerland, Email claudio.schuoler@astrazeneca.comPurpose: Although studies have evaluated benralizumab, a monoclonal IL-5 receptor α antibody in severe eosinophilic asthma (SEA), in real-world settings, additional evidence is needed to further characterize its effectiveness in specific patient populations. …”
Get full text
Article -
784
Diagnostic significance of TGF-β1 in kidney recipients with graft dysfunction
Published 2024-01-01“…Transforming growth factor beta 1 (TGF-β1), which has multiple effects in the body, among the potential indicators of complications.Objective: to assess the diagnostic significance of serum TGF-β1 in kidney recipients with graft dysfunction.Materials and methods. …”
Get full text
Article -
785
Extracellular Vesicles as Precision Delivery Systems for Biopharmaceuticals: Innovations, Challenges, and Therapeutic Potential
Published 2025-05-01“…Recent innovations in surface modification technologies, including ligand and antibody attachment, have further enhanced EVs’ targeting capabilities, making them particularly effective in personalized medicine. …”
Get full text
Article -
786
Phylogenetic analysis of migration, differentiation, and class switching in B cells.
Published 2022-04-01“…B cells undergo rapid mutation and selection for antibody binding affinity when producing antibodies capable of neutralizing pathogens. …”
Get full text
Article -
787
B cells are not drivers of stromal cell activation during acute CNS infection
Published 2025-06-01“…B cell depletion by anti-CD20 antibody also had no adverse effects. Surprisingly, LTβR agonism reduced viral control and parenchymal T cell localization despite increasing stromal cell lymphoid chemokines and PDPN. …”
Get full text
Article -
788
-
789
A SpA+LukAB vaccine targeting Staphylococcus aureus evasion factors restricts infection in two minipig infection models
Published 2025-04-01“…Increasing antimicrobial resistance highlights the urgent need for effective preventative strategies. Antibody-mediated opsonophagocytosis, the key mechanism for protection against S. aureus, is disabled by critical virulence factors such as Staphylococcal protein A (SpA) and leukocidin AB (LukAB). …”
Get full text
Article -
790
The influence of natural immunostimulant on some indicators of specific immunity of carp
Published 2024-09-01“…This was reflected in an increase in the level of total T-lymphocytes, active T-lymphocytes, B-lymphocytes and immunoglobulins. An effective immunostimulating effect was achieved at a dose of 10 mg/kg of fish weight with a duration of use of the preparation for 15–20 days. …”
Get full text
Article -
791
Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease
Published 2025-07-01Get full text
Article -
792
An FPGA-Based SiNW-FET Biosensing System for Real-Time Viral Detection: Hardware Amplification and 1D CNN for Adaptive Noise Reduction
Published 2025-01-01“…The SiNW-FET biosensor, functionalized with antibodies specific to viral antigens, detects impedance shifts caused by antibody–antigen interactions, providing a highly sensitive platform for viral detection. …”
Get full text
Article -
793
Overcoming challenges of developing a live-attenuated dengue vaccine and the path forward
Published 2025-03-01“…Additional immunogenicity analysis across phase I/II/III trials revealed engagement of long-lasting tetravalent, functional antibody, and cell-mediated immune responses directed against the structural and nonstructural components of the vaccine, irrespective of baseline serostatus. …”
Get full text
Article -
794
MANAGEMENT OF BLEEDING IN A PATIENT WITH ACQUIRED HAEMOPHILIA A: A CASE REPORT
Published 2024-12-01“…Objective: Acquired haemophilia A (AHA) is a blood clotting disorder caused by the presence of autoantibodies that interfere with the function of factor VIII, often called factor VIII inhibitor (1). …”
Get full text
Article -
795
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition
Published 2025-08-01“…Sclerostin, an antagonist of Wnt signaling, is elevated in MM patients, and its inhibition with a neutralizing antibody (Scl-ab) has been shown to restore osteoblast function in mouse models of MM. …”
Get full text
Article -
796
Current approaches to therapy for complications of bone metastases from breast cancer
Published 2014-07-01“…Denosumab, a fully human monoclonal antibody to RANKL, suppresses the forma- tion and functional activity of osteoclasts, thus inhibiting bone resorption.The results of a registration study have indicated that denosumab is not only as effective as zoledronic acid, but also can reduce the risk of BMRCs and significantly delay time to the first and further skeletal complications, including the need for radiotherapy, the development of hypercalcemia and pathological fractures. …”
Get full text
Article -
797
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Published 2025-01-01“…Thus, enabling the study of anti-cancer-therapy effects. Here, we analyzed potential cardiac side effects of antibody-mediated PD-L1 inhibition in the preclinical B16F10-GCV mouse model after tumor elimination and 2 weeks recovery (50 days after tumor inoculation). …”
Get full text
Article -
798
CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
Published 2016-01-01“…It has been demonstrated that ademetionine showed a statistically significant analgetic effect (decrease in VAS pain), improved knee function and reduced symptoms in knee joints (as measured by KOOS subscales), and did not influence the levels of systemic inflammation or cartilage destruction biomarkers. …”
Get full text
Article -
799
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
Published 2021-11-01“…Background Natural killer (NK) cells require a functional lytic granule machinery to mediate effective antitumor responses. …”
Get full text
Article -
800
Dynamical Analysis of Secondary Dengue Viral Infection with Multiple Target Cells and Diffusion by Mathematical Model
Published 2022-01-01“…Understanding disease mechanisms through mathematical modeling is one of the most effective tools for this purpose. The aim of this manuscript is to develop and analyze a dynamical system of PDEs that describes the secondary infection caused by DENV, considering (i) the diffusion due to spatial mobility of cells and DENV particles, (ii) the interactions between multiple target cells, DENV, and antibodies of two types (heterologous and homologous). …”
Get full text
Article